HOME SUBSCRIPTIONS CURRENT ISSUE PAST ISSUES CARDIOSOURCE SEARCH HELP FEEDBACK		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Figures Only Full Text Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Email this article to a friend Related articles in JACC Similar articles in this journal Similar articles in ISI Web of Science Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via ISI Web of Science (6) Citing Articles via Google Scholar Google Scholar Articles by Hermida, R. C. Articles by López, J. E. Search for Related Content PubMed PubMed Citation Articles by Hermida, R. C. Articles by López, J. E.

FOCUS ISSUE: ASPIRIN: VIEWPOINT

Aspirin Administered at Bedtime, But Not on Awakening, Has an Effect on Ambulatory Blood Pressure in Hypertensive Patients

Ramón C. Hermida, PhD^_*,_*, Diana E. Ayala, MD, PhD^_*, Carlos Calvo, MD, PhD and José E. López, MD, PhD

^_* Department of Bioengineering and Chronobiology Laboratories, University of Vigo, Campus Universitario, Vigo, Spain
Hypertension and Vascular Risk Unit, Hospital Clínico Universitario, Santiago de Compostela, Spain

Manuscript received June 23, 2004; revised manuscript received August 20, 2004, accepted August 23, 2004.

^_* Reprint requests and correspondence: Dr. Ramón C. Hermida, Bioengineering and Chronobiology Labs, E.T.S.I. Telecomunicación, Campus Universitario, Vigo (Pontevedra) 36200, Spain. (Email: rhermida{at}tsc.uvigo.es).

OBJECTIVES: The purpose of this research was to investigate in untreated hypertensive patients the effects on ambulatory blood pressure (BP) of aspirin (ASA) administered at different times of the day.

BACKGROUND: Previous studies have shown that ASA produces an administration time-dependent inhibition of angiotensin II. Low-dose ASA has also been shown to reduce BP when administered before bedtime, as opposed to upon awakening, in normotensive and hypertensive volunteers, and in pregnant women at high risk for preeclampsia.

METHODS: We studied 328 untreated patients with grade 1 hypertension, 44.0 ± 12.6 years of age, randomly divided into three groups: nonpharmacological hygienic-dietary recommendations, the same recommendations and ASA (100 mg/day) on awakening, or the same recommendations and ASA before bedtime. Blood pressure was measured every 20 min during the day and every 30 min at night for 48 consecutive h before and after 3 months of intervention.

RESULTS: After three months of nonpharmacological intervention, there was a small and nonsignificant reduction of BP (<0.2 mm Hg; p = 0.648). Blood pressure was slightly elevated after aspirin on awakening (2.6/1.6 mm Hg in the 24-h mean of systolic/diastolic BP; p = 0.002). A significant BP reduction, however, was observed in the patients who received aspirin before bedtime (6.8/4.6 mm Hg in systolic/diastolic BP; p < 0.001).

CONCLUSIONS: This prospective trial documents a significant administration time-dependent effect of low-dose ASA on BP in untreated hypertensive patients. The timed administration of low-dose ASA could provide a valuable approach, beyond the secondary prevention of cardiovascular disease, in the added BP control of patients with mild essential hypertension.

Abbreviations and Acronyms   ABPM = ambulatory blood pressure monitoring   ASA = aspirin   BMI = body mass index   BP = blood pressure   COX = cyclooxygenase   DBP = diastolic blood pressure   HDR = hygienic-dietary recommendations   HR = heart rate   NSAID = non-steroidal anti-inflammatory drug   PROBE = prospective, randomized, open-label, blinded end point   SBP = systolic blood pressure

Related articles in JACC:

Aspirin: A Novel Antihypertensive Drug?: Or Two Birds With One Stone?

Franz H. Messerli
JACC 2005 46: 984-985. [Full Text]  

This article has been cited by other articles:

				Other articles noted Evid. Based Med., April 1, 2006; 11(2): 63 - 64. [Full Text] [PDF]

				F. H. Messerli Aspirin: A Novel Antihypertensive Drug?: Or Two Birds With One Stone? J. Am. Coll. Cardiol., September 20, 2005; 46(6): 984 - 985. [Full Text] [PDF]